Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
albuterol sulfate + aspirin + nitroglycerin + epinephrine + dextrose + diphenhydramine
- Development stage
- Unknown
- Lead developer
- Best Dental Kit
- Modality
- Small Molecules
- Administration
- Inhalation, Intramuscular, Oral, Sublingual
01
Overview
**Albuterol sulfate + aspirin + nitroglycerin + epinephrine + dextrose + diphenhydramine** is a co-packaged dental-office emergency medication kit marketed by Best Dental Kit. The kit contains separately packaged small-molecule medicines for several acute emergencies: epinephrine for Type I allergic reactions and anaphylaxis; albuterol for bronchospasm; diphenhydramine for histamine-mediated allergic symptoms; nitroglycerin and aspirin for suspected ischemic cardiac events; and dextrose for hypoglycemia. Epinephrine is the key component for the stated anaphylaxis-related use and acts as a non-selective alpha- and beta-adrenergic receptor agonist. The Basic and Deluxe Dental Emergency Kit products are listed in DailyMed; the Deluxe kit additionally includes pediatric epinephrine and liquid diphenhydramine presentations. The product labeling has not been approved by the FDA as safe and effective.
- Brand names
- Basic Dental Emergency KitDeluxe Dental Emergency Kit
- Other names
- albuterol sulfate + aspirin + dextrose + diphenhydramine hydrochloride + epinephrine + nitroglycerinDental Emergency Kit
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)ADRA2A (α2A)ADRA1A (α1A)ADRB2 (β2)ADRB1 (β1)sGC (Soluble Guanylyl Cyclase)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on albuterol sulfate + aspirin + nitroglycerin + epinephrine + dextrose + diphenhydramine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on albuterol sulfate + aspirin + nitroglycerin + epinephrine + dextrose + diphenhydramine.